Example: Heart Attack

Clinical Trials on Staphylococcal Skin Infections

Total 23 results

  • NCT02814916
    Recruiting
    Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children, Known or Suspected to be Caused by Susceptible Gram-positive Organisms, Including MRSA
    Conditions: Methicillin-Resistant Staphylococcus Aureus, Bacterial Infections, Staphylococcal Skin Infections
  • NCT01431326
    Completed
    Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
    Conditions: Adenovirus, Anesthesia, Anxiety, Anxiolysis, Autism, Autistic Disorder, Bacterial Meningitis, Bacterial Septicemia, Benzodiazepine, Bipolar Disorder, Bone and Joint Infections, Central Nervous System Infections, Convulsions, Cytomegalovirus Retinitis, Early-onset Schizophrenia Spectrum Disorders, Epilepsy, General Anesthesia, Gynecologic Infections, Herpes Simplex Virus, Infantile Hemangioma, Infection, Inflammation, Inflammatory Conditions, Intra-abdominal Infections, Lower Respiratory Tract Infections, Migraines, Pain, Pneumonia, Schizophrenia, Sedation, Seizures, Skeletal Muscle Spasms, Skin and Skin-structure Infections, Treatment-resistant Schizophrenia, Urinary Tract Infections, Withdrawal, Sepsis, Gram-negative Infection, Bradycardia, Cardiac Arrest, Cardiac Arrhythmia, Staphylococcal Infections, Nosocomial Pneumonia, Neuromuscular Blockade, Methicillin Resistant Staphylococcus Aureus, Endocarditis, Neutropenia, Headache, Fibrinolytic Bleeding, Pulmonary Arterial Hypertension, CMV Retinitis, Hypertension, Chronic Kidney Diseases, Hyperaldosteronism, Hypokalemia, Heart Failure, Hemophilia, Heavy Menstrual Bleeding, Insomnia
  • NCT01419184
    Completed
    Daptomycin Versus Vancomycin in Participants With Skin Infections Due to MRSA
    Conditions: Staphylococcal Skin Infections
  • NCT02566928
    Unknown status
    Patient-Centered Comparative Effectiveness Research (CER) Study of Home-based Interventions to Prevent CA-MRSA Infection Recurrence
    Conditions: Methicillin-Resistant Staphylococcus Aureus, Recurrence, Staphylococcal Skin Infections, Antibiotic Resistance
  • NCT02582203
    Completed
    Clinical and Economic Outcomes of Ceftaroline Fosamil for ABSSSI Documented or at Risk of MRSA
    Conditions: Skin Diseases, Infectious, Staphylococcal Skin Infections
  • NCT00513799
    Completed
    The Natural History of Community-Associated MRSA Infections and Decolonization Strategies
    Conditions: Abscesses, Furunculosis, Staphylococcus Aureus, Staphylococcal Skin Infections
  • NCT01105767
    Completed
    Methicillin-resistant Staphylococcus Aureus (MRSA) Skin and Soft Tissue Infection (SSTI) Prevention in Military Trainees
    Conditions: Staphylococcus Aureus, MRSA Skin Infections, Staphylococcal Skin Infections
  • NCT00719810
    Completed
    Safety and Efficacy Study of a Fluoroquinolone to Treat Complicated Skin Infections
    Conditions: Skin Structure Infections, Bacterial Skin Diseases, Staphylococcal Skin Infections
  • NCT01018641
    Completed
    An Evaluation Of Three Dose Levels Of 3-Antigen Staphylococcus Aureus Vaccine (SA3Ag) In Healthy Adults
    Conditions: Bacterial Infections, Staphylococcal Vaccines, Immunotherapy, Active, Staphylococcal Skin Infections, Staphylococcal Infections
  • NCT00646958
    Completed
    Safety and Efficacy Study of Oxazolidinones to Treat Uncomplicated Skin Infections
    Conditions: Infectious Skin Diseases, Bacterial Skin Diseases, Staphylococcal Skin Infections, Streptococcal Infections, Abscess
  • NCT00737269
    Completed
    A Complicated Skin and Soft-tissue Infection Patient Registry
    Conditions: Staphylococcal Skin Infections, Diabetic Foot Infections, Surgical Wound Infection, Abscess, Cellulitis
  • NCT01030731
    Completed
    Pharmacokinetic Study,Ceftobiprole,Healthy Volunteers,Healthy Patients With End Stage Renal Disease
    Conditions: Staphylococcal Skin Infections, Streptococcal Infections
  • NCT01026558
    Completed
    A Study Evaluating the Pharmacokinetics of Ceftobiprole When Taken by Obese Patients
    Conditions: Obesity, Staphylococcal Skin Infections, Streptococcal Infections
  • NCT01026740
    Completed
    Evaluation of Penetration of Ceftobiprole Into Soft Tissue Determined by Microdialysis in Healthy Volunteers
    Conditions: Staphylococcal Skin Infections, Streptococcal Infections
  • NCT01026636
    Completed
    A Single-Dose Pharmacokinetics and Safety Study of Ceftobiprole in Pediatric Patients =3 Months to <18 Years of Age
    Conditions: Staphylococcal Skin Infections, Streptococcal Infections
  • NCT00228982
    Completed
    Ceftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure Infections
    Conditions: Skin Diseases, Infectious, Skin Diseases, Bacterial, Staphylococcal Skin Infections
  • NCT00210899
    Completed
    Ceftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure Infections
    Conditions: Skin Diseases, Infectious, Skin Diseases, Bacterial, Staphylococcal Skin Infections
  • NCT00731783
    Completed
    Staphylococcus Aureus Decolonization Study
    Conditions: Staphylococcal Skin Infections, Abscesses, Furunculosis, Staphylococcus Aureus, MRSA Infection
  • NCT00463801
    Terminated
    Safety and Efficacy of Daptomycin for the Treatment of Complicated Skin and Skin-structure Infections
    Conditions: Staphylococcal Skin Infections
  • NCT01198262
    Completed
    Rapid Test to Detect Staphylococcus Aureus in Blood and Wound Infections
    Conditions: Staphylococcus Aureus, Staphylococcal Skin Infections, Bacteremia
  • NCT00475930
    Completed
    Chlorhexidine Impregnated Cloths to Prevent Skin and Soft Tissue Infections in Marine Officer Candidates
    Conditions: Staphylococcus Aureus, Community-Acquired Infections, Staphylococcal Skin Infections
  • NCT00514527
    Completed
    A Study for Patients With Complicated Skin and Skin Structure Infections
    Conditions: Staphylococcal Skin Infections, Wounds and Injuries, Abscess, Cellulitis, Streptococcal Infections
  • NCT00492271
    Terminated
    First Time in Man Trial for Friulimicin B
    Conditions: Community Acquired Pneumonia, Staphylococcal Skin Infections
Medical Conditions
Sponsors and Collaborators
Drug Interventions
Conditions
Rare Diseases
Drug Interventions
Dietary Supplements
Sponsor/Collaborators
Locations